SCHEMBL10013641

SCHEMBL10013641

CNCCNC(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13883575 0.93 HDAC3 (0.33)
SCHEMBL10866810 0.87 HDAC3 (0.41)
SCHEMBL14571201 0.84 SMN1; SMN2 (0.48)
SCHEMBL27436145 0.84 SMN1; SMN2 (0.48)
SCHEMBL17488363 0.80 KDM4E (0.50)
SCHEMBL23475911 0.79 CA3 (0.38)
SCHEMBL27446754 0.79 MEN1 (0.44)
SCHEMBL14002750 0.77 ALDH1A1 (0.48)
SCHEMBL1387175 0.77
SCHEMBL6755662 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4212180-A1 MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF The Scripps Research Institute (US) 2023-07-19 EP disclosed
US-8999965-B2 Anthraquinone based near IR emitting compounds and uses thereof Life Technologies Corporation (US) 2015-04-07 US disclosed
US-20120028249-A1 ANTHRAQUINONE BASED NEAR IR EMITTING COMPOUNDS AND USES THEREOF Life Technologies Corporation (US) 2012-02-02 US disclosed